Recruiting Influenza Studies in Chicago
A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subty...
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
The study regimen will be administered on an outpatient basis and all medications are administered intravenously (IV). Subjects will receive treatment on Day 1 and Day 15 of each 28-day cycle consisti...
About Influenza Clinical Trials in Chicago
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It causes millions of illnesses and thousands of deaths annually. Prevention through vaccination is the primary strategy, with antiviral medications available for treatment.
There are currently 2 influenza clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 436 participants. Research is being sponsored by AstraZeneca, Tiago Biachi de Castria. Clinical trial participation is free and participants receive study-related medical care at no cost.
Influenza Clinical Trials in Chicago — FAQ
Are there influenza clinical trials in Chicago?
Yes, there are 2 influenza clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What influenza treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for influenza.
Data updated March 2, 2026 from ClinicalTrials.gov